This opposing trend, together with the previously described antagonistic enrichment in fatty acid biosynthesis (Fig 2A and D), indicates that MIC26 deletion rewires glycolytic function to drive lipogenesis in normoglycemia with an antagonistic effect in hyperglycemia. Here, APOO is linked to Hyperglycemia.